Skip to main content
Caplight Logo









Suzhou Lanma Medical Technology Co., Ltd.

Suzhou Lanma Medical Technology Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttp://www.lanmabio.com/

Last Round

Early Funding

Mar 1, 2022

Company Overview

Suzhou Lanma Medical Technology Co., Ltd. is a biotechnology company that develops and produces cell-based immunotherapy products, specifically focusing on tumor-infiltrating lymphocyte (TIL) therapy for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

tumor-infiltrating lymphocyteTIL therapycell therapysolid tumor treatmentimmunotherapyautologous cell therapybiotechnologyclinical stage biotechcell expansiononcology researchnext-gen immunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Lanma Medical Technology Co., Ltd. Comparables

Compare Suzhou Lanma Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou Lanma Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hangzhou Huasai Biomedicine Co., Ltd.
89%
Shanghai Juncell Therapeutics Co., Ltd.
89%
Grit Biotherapeutics
84%

Suzhou Lanma Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 1, 2022

Suzhou Lanma Medical Technology Co., Ltd. Investors

Notable investors and investment history

Suzhou Lanma Medical Technology Co., Ltd. investors
InvestorRounds
IDG CapitalEarly Funding
Boyuan CapitalEarly Funding
SND Ventures GroupEarly Funding
Huagai CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2022

    Led by IDG Capital and Boyuan Capital.

Suzhou Lanma Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Suzhou Lanma Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Suzhou Lanma Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2020
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?